top of page

Search

NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1

Apr 12, 2025
1 min read

Check out this new event and grab a seat!

Recent Posts

Emerging Clinical Evidence for the Use of ENHERTU in HER2+ Breast Cancer ~ 7/29/26

Emerging Clinical Evidence for the Use of ENHERTU in HER2+ Breast Cancer ~ 7/29/26

Advocate for Change Join the Massachusetts Biomarker Testing Coalition Lobby Day, NEXT WEEK May 13th

Advocate for Change Join the Massachusetts Biomarker Testing Coalition Lobby Day, NEXT WEEK May 13th

NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress

NEW Event! From Mutation to Management: Practical Nursing Strategies in HER2-Mutant NSCLC ~ 5.14.26 @ ONS Congress

Comments

bottom of page